The reported statements, read against the company's own industry.
What stands out
Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
10.25BCNY
1.52B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
37.72BCNY
5.61B · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-35.27%
Updated Aug 20, 2026
Beta
1.01x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-42.96%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
10.25BCNY
1.52B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
103.44BCNY
15.38B · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
-2.78x
Updated Aug 20, 2026
Price to Sales (TTM)
0.2633x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.27×.Updated Aug 20, 2026
Price to Book (MRQ)
0.2220x
Updated Aug 20, 2026
Enterprise to Revenue
2.74x
Updated Aug 20, 2026
Enterprise to EBITDA
-75.04x
Updated Aug 20, 2026
Gross Margin
15.97%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 5.6%.Updated Aug 20, 2026
Profit Margin
-35.27%
Updated Aug 20, 2026
Operating Margin
7.41%
Updated Aug 20, 2026
Return on Assets (TTM)
-0.36%
Updated Aug 20, 2026
Return on Equity (TTM)
-16.65%
Updated Aug 20, 2026
Revenue (TTM)
37.72BCNY
5.61B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
8.28CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
32.30%
Updated Aug 20, 2026
Gross Profit (TTM)
2.11BCNY
313.92M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
-1.38BCNY
-205.01M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-13.30BCNY
-1.98B · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-77.05%
Updated Aug 20, 2026
Operating Cash Flow (TTM)
412.00MCNY
61.27M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
1.76BCNY
262.01M · vs all stocks (USD)
Updated Aug 20, 2026
5-Year Average Dividend Yield
4.27%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
0.00%
Updated Aug 20, 2026
Minority Interest (Equity)
37.72BCNYFY2025 · Dec 31, 2025
Revenue
35.86BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
31.12BCNYFY2025 · Dec 31, 2025
Gross Profit
4.74BCNYFY2025 · Dec 31, 2025
Operating Income
889.11MCNY
132.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-14.53BCNYFY2025 · Dec 31, 2025
Income Tax Expense
997.44MCNYFY2025 · Dec 31, 2025
Net Income
-15.52BCNYFY2025 · Dec 31, 2025
EBIT
-12.13BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-2.78BCNYFY2025 · Dec 31, 2025
Research & Development
35.61MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
1.45BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
446.87MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
189.76MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.40BCNYFY2025 · Dec 31, 2025
EPS (Basic)
-2.94CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-2.94CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
4.52BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
4.52BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-15.52BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
2.24BCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
11.48BCNYFY2025 · Dec 31, 2025
Free Cash Flow
11.23BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
11.21BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-15.52BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.58BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.52BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
18.90BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-244.31MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-26.93MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-467.58MCNYFY2025 · Dec 31, 2025
Sale of Investments
733.81MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-489.59MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-494.60MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
4.24BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-10.46BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.93BCNYFY2025 · Dec 31, 2025
Other Financing Charges
-245.89MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-9.40BCNYFY2025 · Dec 31, 2025
Shares Outstanding
4.51BSharesUpdated Aug 20, 2026
Float Shares
2.80BSharesUpdated Aug 20, 2026
% Held by Insiders
9.40%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
35.28%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
10.61BCNY
1.58B · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
2.35CNYUpdated Aug 20, 2026
Total Debt (MRQ)
66.71BCNY
9.92B · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.8121x
Updated Aug 20, 2026
Current Ratio (MRQ)
1.36x
Updated Aug 20, 2026
Book Value per Share (MRQ)
9.91CNYUpdated Aug 20, 2026
Total Assets
233.20BCNY
34.68B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
150.48BCNYFY2025 · Dec 31, 2025
Total Liabilities
149.84BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
82.72BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
41.56BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
108.28BCNYFY2025 · Dec 31, 2025
Cash
11.21BCNYFY2025 · Dec 31, 2025
Cash Equivalents
1.46BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
12.67BCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.71BCNYFY2025 · Dec 31, 2025
Inventory
59.29BCNYFY2025 · Dec 31, 2025
Accounts Payable
15.76BCNYFY2025 · Dec 31, 2025
Short-term Debt
31.06BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.53BCNYFY2025 · Dec 31, 2025
Long-term Debt
36.75BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.32MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
4.51BCNYFY2025 · Dec 31, 2025
Retained Earnings
37.82BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
83.36BCNY
12.40B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
2.03CNYUpdated Aug 20, 2026
52-Week High
4.56CNYUpdated Aug 20, 2026
52-Week Change
-42.96%
vs all stocks
Updated Aug 20, 2026
Beta
1.01x
vs all stocks
Updated Aug 20, 2026
50-Day MA
2.27CNYUpdated Aug 20, 2026
200-Day MA
2.90CNYUpdated Aug 20, 2026
Avg 10-Day Volume
82.65MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
74.86MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-2.94CNYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 0.32Receivables vs revenue divergence: 5.42